TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,988
|
3,874
|
3,307 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
265
|
-432
|
22 |
| EBITDA |
346
|
-334
|
295 |
| Total assets |
3,451
|
3,041
|
3,616 |
| Current assets |
2,848
|
2,380
|
2,973 |
| Current liabilities |
951
|
728
|
878 |
| Equity capital |
2,492
|
2,305
|
2,730 |
| - share capital |
2,196
|
2,273
|
2,267 |
| Employees (average) |
21
|
23
|
20 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
72.2%
|
75.8%
|
75.5% |
| Turnover per employee |
238
|
168
|
165 |
| Profit as a percentage of turnover |
5.3%
|
-11.2%
|
0.7% |
| Return on assets (ROA) |
7.7%
|
-14.2%
|
0.6% |
| Current ratio |
299.5%
|
326.9%
|
338.6% |
| Return on equity (ROE) |
10.6%
|
-18.7%
|
0.8% |
| Change turnover |
1,245
|
558
|
1,249 |
| Change turnover % |
33%
|
17%
|
61% |
| Chg. No. of employees |
-2
|
3
|
4 |
| Chg. No. of employees % |
-9%
|
15%
|
25% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.